Alexandra Flemming

Alexandra Flemming is a German biologist, academic, and the editor in chief of Nature Reviews Immunology.

Education

Flemming studied molecular biology at the University of Freiburg before moving to South Africa to study infectious immunology at the University of Cape Town.[1]

She obtained her PhD at the University of Freiburg's Max-Planck Institute for Immunology and won awards for her thesis about the role of the B cell signaling protein SLP‑65 in the malignant transformation of B cells.[1] She continued studying as a European Molecular Biology Organization fellow and as a Human Frontiers Science Programme fellow, seconded to Cancer Research UK in London.[1]

Career

Flemming is employed in the department of molecular immunology in the faculty of biology at the University of Freiburg.[2]

She joined Nature Reviews Drug Discovery as an associate editor before becoming the editor in chief of Nature Reviews Immunology in 2017.[1]

References

  1. ^ a b c d "About the Editors | Nature Reviews Immunology". www.nature.com. Retrieved 2022-04-05.
  2. ^ "Alexandra Flemming - profile". www.aminer.org. Retrieved 2022-04-05.

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.